Menu
Menu
Perinatal Mood & Anxiety Disorders (PMADs) are the number one complication during pregnancy and childbirth. This illness affects over 20% of pregnant and postpartum women and has increased exponentially since COVID. Any woman who can be identified, as at risk for PMADs during pregnancy, using validated screening tools, can be proactively assessed, diagnosed, and treated, potentially erasing the emergency/crisis intervention for a new postpartum mom. With evidence based multidisciplinary treatment modalities, all women get better, and return to their normal baseline of mental health. Gestational diabetes affects approximately 4-6% of the same population, and the medical community is always assessing for that illness, why is it, that an illness that affects upwards of 4x that number is not given the same attention and respect. If you are a healthcare provider who treats women in the childbearing age range, work in behavioural mental health, or a paediatrician, this information will give you what you need to start to be able to identify these women, give proper screening tools, and refer to resources and treatment that is appropriate for this temporary and treatable illness.
Planning Committee Disclosure - No relevant relationships
All members of the PESI, Inc. planning committee have provided disclosures of financial relationships with ineligible organizations and any relevant non-financial relationships prior to planning content for this activity. None of the committee members had relevant financial relationships with ineligible companies or other potentially biasing relationships to disclose to learners. For speaker disclosures, please see the faculty biography.
PESI Australia, in collaboration with PESI in the USA, offers quality online continuing professional development events from the leaders in the field at a standard recognized by professional associations including psychology, social work, occupational therapy, alcohol and drug professionals, counselling and psychotherapy. On completion of the training, a Professional Development Certificate is issued after the individual has answered and submitted a quiz and course evaluation. This program is worth 2.0 hours CPD for points calculation by your association.
| File type | File name | Number of pages | |
|---|---|---|---|
| Manual - Maternal Mental Health and Pregnancy (4.28 MB) | 31 Pages | Available after Purchase |
Lisa Tremayne, RN, PMH-C, CBC, is both a survivor and dedicated advocate of improving the standard of care and raising awareness for Perinatal Mood and Anxiety Disorders. In 2005, Lisa was involved in the development of New Jersey’s, first in-nation universal mandatory screening program for prenatal and postpartum depression. In 2017, Lisa created and directed New Jersey’s first Center for Perinatal Mood and Anxiety Disorders (PMAD), which offers comprehensive integrated care (individual therapy, medication, peer group support, and more) to new and expectant parents. Lisa also co-founded and acts as the president of the Bloom Foundation for Maternal Wellness. The Bloom Foundation’s mission is to create a new standard of care for women throughout the perinatal period to ensure that every suffering new and expecting parent receives the care they need.
Speaker Disclosures:
Financial: Lisa Tremayne is the founding director of the Perinatal Mood and Anxiety Disorders Center and the Bloom Foundation for Maternal Wellness. She receives a speaking honorarium from PESI, Inc. She has no relevant financial relationships with ineligible organizations.
Non-financial: Lisa Tremayne has no relevant non-financial relationships.
Please wait ...